The Claim
Older weight loss drugs have adverse benefit-to-risk profiles, and none of the evaluated drugs—lorcaserin, phentermine/topiramate, and naltrexone-bupropion—have been demonstrated to reduce mortality.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
The older weight loss pills people used to take don’t do more good than harm, and none of them have been proven to help people live longer.
See the scientific wording
Older weight loss drugs have adverse benefit-to-risk profiles, and none of the evaluated drugs (lorcaserin, phentermine/topiramate, naltrexone-bupropion) have been demonstrated to reduce mortality.
What the research says
1 studyStudy: Reducing the Risk of Obesity: Defining the Role of Weight Loss Drugs
The study looked at the same weight-loss pills mentioned in the claim and found they don’t help people live longer, and they come with more risks than benefits — so the claim is right.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.